A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED)

Clinical trial NCT06329791 · UNKNOWN

Trial details

NCT number: NCT06329791
Sponsor: Azura Ophthalmics
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2024-05-28
Primary completion: 2024-12-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.